Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-039272)

Filing Details

Accession Number:: 0001209191-20-039272
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-06-29 20:13:05
Reporting Period:: 2020-06-25

Accepted Time:: 2020-06-29 20:13:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1419041	Forte Biosciences Inc.	FBRX	Pharmaceutical Preparations (2834)	261243872

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1612842	A. Paul Wagner	C/O Forte Biosciences, Inc. 1124 W. Carson Street, Mrl Bldg. 3-320 Torrance CA 90502	See Remarks	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-06-25	7,000	$14.48	2,279,049	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average share price of an aggregate total of 7,000 shares purchased in the price range of $14.1620 to $14.9899 by the Reporting Person. The Reporting Person undertakes to provide upon requestby the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.